Figure 12

Regression of in vitro THP-1 IL-1β release at 25 μg/ml verses day-7 in vivo pathology scores for the MWCNT instillation conditions.
Regression of in vitro THP-1 IL-1β release at 25 μg/ml verses day-7 in vivo pathology scores for the MWCNT instillation conditions.